Cardiovascular Regeneration and Stem Cell Therapy

- Contributors

- Preface

- Introduction

Part I Stem Cell Biology
1. Homing of Stem Cells and Tissue Injury
2. Adult Stem Cell Plasticity: Lineage potential on a Continuum
3. Embryonic Stem Cells and Cardiogenesis
4. Mesenchymal Stem Cell-Derived Cardiomyogenic Cells
5. Bone Marrow Cells and Vascular Growth
6. Progenitor Cells and Vascular Repair

Part II Cardiac Progenitor Cells in the Adult Heart
7. Cardiac Side Population Cells: Phenotype and Functional Significance
8. Phenotype and Function of c-kit Positive-Derived Amplifying Myocytes
9. Cardiac Stem Cells and their Niches
10. Activation of the Local Regenerative System of the Heart

Part III Progenitor Cells and the Diseased Heart
11. Embryonic Stem Cells and Myocardial Regeneration
12. Bone Marrow-Derived Cells in Myocardial Repair and Regeneration
13. Endothelial Progenitor Cells And The Infarcted Heart
14. Cytokines and Heart Remodeling
15. IGF-1, Muscle Progenitors and Heart Failure

Part IV Cardiac Progenitor Cells and Heart Failure
16. Cardiac Stem Cells and the Diabetic Cardiomyopathy
17. Stem Cells and Cardiac Aging
18. Bioengineered Scaffolds: Myocytes, Endothelial Cells and Cardiac Repair
19. Gene Therapy and Cellular Therapy in Cardiac Repair
20. Cardiac Stem Cells and the Failing Heart
21. Myocardial Infarction: Risks and Hope

Part V Future Directions
22. Conclusions - Future Directions

- Index

Annarosa Leri MD is a lead investigator in the Cardiovascular Research Institute at the New York Medical College where this field of investigation began. She has made major contributions to our understanding of the basic mechanisms involved in stem cell regenerative therapy for the cardiovascular system. Dr. Leri is Professor of Medicine of the Cardiovascular Research Institute of the New York Medical College in Valhalla, New York. She is co-editor and author.
 
Piero Anversa MD Dr. Anversa is Director of the Cardiovascular Research Institute at New York Medical College, and is the founder of the field of stem cell therapy and regenerative cardiovascular medicine. In recognition of his contributions, Dr. Anversa received the 2004 Distinguished Scientist Award of the American Heart Association.
 
Professor William H Frishman MD is one of the leading cardiovascular investigators in the world, with emphasis in the area of cardiovascular therapeutics. He is author, co-author, editor and co-editor of 12 textbooks and 800 original articles and chapters. He is currently supplements editor of the American Journal of Medicine, co-editor of the Year Book of Medicine and co-editor-in-chief of the journal Cardiology in Review. Dr. Frishman is the Rosenthal Professor and Chairman of the Department of Medicine at New York Medical College in Valhalla, New York. He is co-editor and co-author.

"This book brings together the world's foremost expertsin the areas of stem cell biology and their role in cardiovascularpatho-physiology. [A] highly enjoyable review of the currentknowledge ... and it succeeds in covering the current knowledgeauthoritatively. An essential book for clinicians and fundamentalscientists working in this area." ( Cardiology News ,December 2008)
"The authors have played a major role in developing thisnew topic...and it is of high relevance in ongoing clinicaltrials and future treatment perspectives." ( Journal of theAmerican Medical Association )